Tumour stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma Physician's Weekly, 21 May 2023 Bookmark 1. The tumour stroma ratio (TSR) is a prognostic biomarker for predicting recurrence-free survival following…